Tuesday, July 16, 2019
Omnicell, Inc., a leading provider of medication management and supply chain solutions for health systems, today announced that Northern Arizona Healthcare will partner with Omnicell to leverage the company’s automation and intelligence solutions to enhance efficiency, control, and safety of medication management at their flagship hospitals, Flagstaff Medical Center and Verde Valley Medical Center.
Through this ten year, sole source agreement, the healthcare system will streamline sterile compounding processes in Central Pharmacy and improve workflows in patient care areas through Omnicell’s industry-leading automation solutions. Northern Arizona Healthcare will also leverage the company’s cloud-based predictive intelligence platform and expert services, known as Performance Center™, to monitor pharmacy operations and identify opportunities to help improve efficiency, regulatory compliance, and patient outcomes.
Northern Arizona Healthcare joins more than 5,500 health systems across the United States that are leveraging Omnicell’s automation and intelligence solutions to help improve management of the pharmacy supply chain. The company recently launched its vision of Autonomous Pharmacy, a roadmap to develop a zero error, fully automated medication management infrastructure. Leveraging automation, data intelligence, and expert services, the Autonomous Pharmacy will empower pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction.
In the Autonomous Pharmacy vision, every dose of medication is viewed as a node on the network that carries valuable data about patients, inventory, and more.
“The ability to leverage this robust intelligence will not only help to improve our operational and financial outcomes, but more importantly will help improve patient outcomes,” said Scott Waldrop, NAH System Director of Pharmacy Services.
“Using intelligent technology and automation, we’re working to incorporate a streamlined approach that moves clinicians away from manual tasks and to make a greater impact on clinical care,” said Scott Seidelmann, executive vice president and chief commercial officer at Omnicell.
